Largest Market Share by Therapeutic Area

In 2022, the “Other” therapeutic area segment captured the largest share of the market. This category includes various medical fields such as oncology, hematology, dentistry, and more. Cancer, for example, remains one of the toughest challenges for patients, not only due to the disease itself but also because of its emotional and physical toll. In addition, the International Diabetes Federation (IDF) reports that the global number of adults with diabetes reached 537 million in 2021, with projections to rise to 643 million by 2030. The increase in Type 1 and Type 2 diabetes diagnoses is primarily driven by factors such as obesity, poor diet, and a lack of exercise. This has led to a surge in the demand for anti-diabetic medications, as the incidence of diabetes continues to rise, contributing to higher healthcare costs globally. As treatment options evolve, advancements in technology and drug formulation have led to significant improvements in the development of medications, particularly in the field of compounding pharmacies, which play a crucial role in offering customized treatments for conditions like autism and rare diseases.

503A U.S. Compounding Pharmacies Market Share by Therapeutic Area, 2022 vs. 2032 (%)

One of the fastest-growing therapeutic areas is hormone replacement therapy (HRT), especially given the aging population in the U.S. Many individuals are turning to HRT to alleviate symptoms such as hot flashes and pain, and in some cases, to help slow the progression of conditions like breast cancer. The increasing prevalence of breast cancer has fueled a higher demand for HRT, highlighting the growing need for personalized care in this sector.

Recent Developments in the 503A Compounding Pharmacies Market

• Wedgewood Pharmacy: In June 2023, Wedgewood Pharmacy, a leading veterinary compounding pharmacy, announced its merger with a pharmacy services and prescription management company. This strategic move is designed to provide customers with faster, more efficient service in veterinary compounding, reflecting the growing demand for customized medications in this sector.
• Optum: In January 2023, Optum introduced a new tool called PriceEdge, aimed at making prescription medications more affordable for consumers. PriceEdge combines direct-to-consumer pricing for common generic drugs with insurance pricing, ensuring that Optum Rx customers always pay the lowest price possible. This tool is part of Optum’s ongoing efforts to improve the cost-efficiency of healthcare and make medications more accessible to the public.
• B. Braun: In November 2020, B. Braun entered into a strategic partnership with Grifols to enhance the safety and efficiency of automated drug delivery systems. By combining Grifols’ automated compounding technology with B. Braun’s Safe Infusion Systems, the partnership aims to provide safer, more reliable drug delivery solutions for patients, marking a significant advancement in the field of sterile compounding.